Skip to content
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Careers
Pipeline
ACER-001 for UCD
ACER-001 for MSUD
EDSIVO™ for vEDS
Osanetant for iVMS
Emetine for Infectious Diseases
Patients & Physicians
Patient Advocacy
Publications
Medical Information Request
Urea Cycle Disorders (UCDs)
Maple Syrup Urine Disease (MSUD)
Vascular Ehlers-Danlos Syndrome (vEDS)
Induced Vasomotor Symptoms (iVMS)
Infectious Diseases
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
About
Pipeline
Investor Relations
Publications
Contact Us
Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations
About
Pipeline
Investor Relations
Publications
Contact Us
Press Releases
Investor Relations
Filter by Year
2021
2020
2019
2018
2017
2016
2015
2014
QUICK
NAV
MENU
MENU
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Careers
Pipeline
ACER-001 for UCD
ACER-001 for MSUD
EDSIVO™ for vEDS
Osanetant for iVMS
Emetine for Infectious Diseases
Patients & Physicians
Patient Advocacy
Publications
Medical Information Request
Urea Cycle Disorders (UCDs)
Maple Syrup Urine Disease (MSUD)
Infectious Diseases
Vascular Ehlers-Danlos Syndrome (vEDS)
Induced Vasomotor Symptoms (iVMS)
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
We use cookies to ensure that we give you the best experience on our website. By using our site, you consent to cookies.
Learn more.
Ok
